207 related articles for article (PubMed ID: 29979714)
1. Construction of an integrated database for hERG blocking small molecules.
Sato T; Yuki H; Ogura K; Honma T
PLoS One; 2018; 13(7):e0199348. PubMed ID: 29979714
[TBL] [Abstract][Full Text] [Related]
2. In silico prediction of hERG inhibition.
Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
5. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.
Wang S; Li Y; Wang J; Chen L; Zhang L; Yu H; Hou T
Mol Pharm; 2012 Apr; 9(4):996-1010. PubMed ID: 22380484
[TBL] [Abstract][Full Text] [Related]
6. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
Durdagi S; Duff HJ; Noskov SY
J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
[TBL] [Abstract][Full Text] [Related]
7. Prospective validation of a comprehensive in silico hERG model and its applications to commercial compound and drug databases.
Doddareddy MR; Klaasse EC; Shagufta ; Ijzerman AP; Bender A
ChemMedChem; 2010 May; 5(5):716-29. PubMed ID: 20349498
[TBL] [Abstract][Full Text] [Related]
8. Determination of hERG channel blockers using a decision tree.
Gepp MM; Hutter MC
Bioorg Med Chem; 2006 Aug; 14(15):5325-32. PubMed ID: 16616507
[TBL] [Abstract][Full Text] [Related]
9. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques.
Ekins S; Balakin KV; Savchuk N; Ivanenkov Y
J Med Chem; 2006 Aug; 49(17):5059-71. PubMed ID: 16913696
[TBL] [Abstract][Full Text] [Related]
10. Modeling of the hERG K+ Channel Blockage Using Online Chemical Database and Modeling Environment (OCHEM).
Li X; Zhang Y; Li H; Zhao Y
Mol Inform; 2017 Dec; 36(12):. PubMed ID: 28857516
[TBL] [Abstract][Full Text] [Related]
11. A critical assessment of combined ligand- and structure-based approaches to HERG channel blocker modeling.
Du-Cuny L; Chen L; Zhang S
J Chem Inf Model; 2011 Nov; 51(11):2948-60. PubMed ID: 21902220
[TBL] [Abstract][Full Text] [Related]
12. Indexing molecules for their hERG liability.
Rayan A; Falah M; Raiyn J; Da'adoosh B; Kadan S; Zaid H; Goldblum A
Eur J Med Chem; 2013 Jul; 65():304-14. PubMed ID: 23727540
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in computational prediction of HERG blockage.
Wang S; Li Y; Xu L; Li D; Hou T
Curr Top Med Chem; 2013; 13(11):1317-26. PubMed ID: 23675938
[TBL] [Abstract][Full Text] [Related]
14. In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology.
Taboureau O; Jørgensen FS
Comb Chem High Throughput Screen; 2011 Jun; 14(5):375-87. PubMed ID: 21470179
[TBL] [Abstract][Full Text] [Related]
15. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.
Thai KM; Ecker GF
Mol Divers; 2009 Aug; 13(3):321-36. PubMed ID: 19219559
[TBL] [Abstract][Full Text] [Related]
16. Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design.
Narayana Moorthy NS; Ramos MJ; Fernandes PA
Curr Drug Targets; 2013 Jan; 14(1):102-13. PubMed ID: 23061466
[TBL] [Abstract][Full Text] [Related]
17. The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis.
Choi KE; Balupuri A; Kang NS
Molecules; 2020 Jun; 25(11):. PubMed ID: 32512802
[TBL] [Abstract][Full Text] [Related]
18. Tuning HERG out: antitarget QSAR models for drug development.
Braga RC; Alves VM; Silva MF; Muratov E; Fourches D; Tropsha A; Andrade CH
Curr Top Med Chem; 2014; 14(11):1399-415. PubMed ID: 24805060
[TBL] [Abstract][Full Text] [Related]
19. hERGCentral: a large database to store, retrieve, and analyze compound-human Ether-à-go-go related gene channel interactions to facilitate cardiotoxicity assessment in drug development.
Du F; Yu H; Zou B; Babcock J; Long S; Li M
Assay Drug Dev Technol; 2011 Dec; 9(6):580-8. PubMed ID: 22149888
[TBL] [Abstract][Full Text] [Related]
20. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
Aronov AM
J Med Chem; 2006 Nov; 49(23):6917-21. PubMed ID: 17154521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
